Category Archives: biology

DNA Script picks up $38.5 million to make DNA production faster and simpler

DNA Script has raised $38.5 million in new financing to commercialize a process that it claims is the first big leap forward in manufacturing genetic material. The revolution in synthetic biology that’s reshaping industries from medicine to agriculture rests on three, equally important pillars. They include: analytics — the ability to map the genome and understand the function of different genes; synthesis — the ability to manufacture DNA to achieve certain functions; and gene editing — the CRISPR-based technologies that allow for the addition or subtraction of […]

Read more

Microbiome testing service uBiome puts its co-founders on administrative leave after FBI raid

The microbiome testing service uBiome has placed its founders and co-chief executives, Jessica Richman and Zac Apte, on administrative leave following an FBI raid on the company’s offices last week. The company’s board of directors have named John Rakow, currently the company’s general counsel, as its interim chairman and chief executive, the company said in a statement. Directors of the company are also conducting an independent investigation into the company’s billing practices, which is being overseen by a special committee of the board. It was only last […]

Read more

Driving down the cost of preserving genetic material, Acorn Biolabs raises $3.3 million

Acorn Biolabs wants consumers to pay them to store genetic material in a bet that the increasing advances in targeted genetic therapies will yield better healthcare results down the line. The company’s pitch is to “Save young cells today, live a longer, better, tomorrow.” It’s a gamble on the frontiers of healthcare technology that has managed to net the company $3.3 million in seed financing from some of Canada’s busiest investors. For the Toronto-based company, the pitch isn’t just around banking genetic material — a practice that’s been […]

Read more

uBiome is jumping into therapeutics with a healthy $83 million in Series C financing

23andMe, IBM and now uBiome is the next tech company to jump into the lucrative multi-billion dollar drug discovery market. The company started out with a consumer gut health test to check whether your intestines carry the right kind of bacteria for healthy digestion but has since expanded to include over 250,000 samples for everything from the microbes on your skin to vaginal health — the largest data set in the world for these types of samples, according to the company. Founder Jessica Richman now says there’s […]

Read more

George Church’s genetics on the blockchain startup just raised $4.3 million from Khosla

Nebula Genomics, the startup that wants to put your whole genome on the blockchain, has announced the raise of $4.3 million in Series A from Khosla Ventures and other leading tech VC’s such as Arch Venture Partners, Fenbushi Capital, Mayfield, F-Prime Capital Partners, Great Point Ventures, Windham Venture Partners, Hemi Ventures, Mirae Asset, Hikma Ventures and Heartbeat Labs. Nebula has also has forged a partnership with genome sequencing company Veritas Genetics. Veritas was one of the first companies to sequence the entire human genome for less than $1,000 in 2015, later […]

Read more